B
BioXcel Therapeutics, Inc. (BTAI)
1.26
0.00 (0.00%)
Get all premium features to the best stock analysis tool
1.26
0.00 (0.00%)
This stock has a consensus price target of $18.69 based on the ratings of 11 analysts. The high is $66.00 and the low is $0.25.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 0.25 | $ 18.69 | $ 66 |
| Change | -80.16% | 1383.33% | 5138.10% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-03-17 | 1249.21% | Rodman & Renshaw | $17 | Initiates Coverage On | Buy |
| 2026-03-05 | 376.19% | HC Wainwright & Co. | $10 → $6 | Maintains | Buy |
| 2025-09-15 | 693.65% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2025-09-12 | 217.46% | Mizuho | $2 → $4 | Maintains | Neutral |
| 2025-08-28 | 693.65% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |